MARKET

Azrieli is Israel's largest real estate company with 1.2 million square meters of space.

The FOCUS Phase IIIb trial results published by 'The Lancet" demonstrate that Ajovy significantly relieves migraines.

The $11 million being paid by Endo is considered a modest amount and could mean Teva's liability on opioid suits is lower than previously thought.

INX's $130 million offering is classified by the SEC as an IPO, and its INX Tokens will be recognized as a security.

Iron Fist will protect the IDF's new Eitan armored fighting vehicle (AFV) and D-9 bulldozers.

UBS gives two scenarios for Teva's share: an upside, in which the target price reaches $17, and a downside in which the target price drops to $1.

The shekel is strengthening again despite disappointing growth data and lower than expected inflation.

No financial details were disclosed of the all-Israeli acquisition deal.

Y.H. Dimri's offer comes just days before the Africa-Israel bondholders are due to vote on which one to accept.

Herzliya-based S&W Media Group specializes in Internet advertising and developing apps for smart TVs.

The Israeli-Canadian medical aesthetics company markets to over 60 countries, with direct marketing in 29 of them.

The Israeli company has initiated a planting program to examine the effects of its technologies on several protein-laden crops, including peas and beans.

After July's lower than expected CPI reading, the Israeli currency has been further weakened by poor second quarter growth figures.

The first half results of Israel's credit card companies show the effect of becoming competitors rather than extensions of the banks.

A freedom of information petition has been filed demanding that the banks reveal their  policies on accounts for proceeds of cryptocurrency trading.

Israeli company NextFerm has unique technology for turning natural yeasts into industrial power players.

Supermarket chains report a shortage of Coca Cola in cans. Coca Cola Israel says it's because of the launch of a new flavor.

The company's electrical stimulation treatment for brain cancer can extend patients' lives by years.

IMF executive Anthony De Lannoy, in Israel for Cyber Week, sees the time coming when the rest of Israel's population will refuse to finance social benefits for non-working haredim.

Although Teva's share price rose 4.06% on Wall Street on Friday, the Israeli pharmaceutical company's market cap still finished the week below the fast-growing DIY website company.

Altshuler Shaham Provident Funds and Pension Ltd. has recorded the second most successful flotation after the TASE itself.

The non-woven fabrics company's second quarter profit was down 90% in comparison with the corresponding quarter of 2018.

Israel's Consumer Price Index fell 0.3% last month, with housing prices nearing their 2017 peak.

The shares workspace company, which recently changed its name to The We Company, has filed an IPO prospectus.

Elbit Systems' orders backlog totaled $9.8 billion at the end of the second quarter.

Veoli is developing a unique inhaler that enables patients to consume cannabis oil in an accurate dosage.

As markets tumble and concern about global recession grows, investors have rushed towards safe haven currencies.

The company reported a tough quarter with a NIS 35 million loss, following a NIS 15 million loss in the preceding quarter and a NIS 35 million loss in the fourth quarter of 2018.

Bank Hapoalim saw second quarter profit fall after selling Isracard and closing international private banking operations.

Berkshire Hathaway has kept its 4% stake in the Israeli pharmaceutical company, costing it hundreds of millions of dollars 'on paper.'

Teva fell over 10% on a bearish Wall Street after Congress members accused it of obstructing a price-fixing probe and Moody's revised its outlook to negative.